Vitae Pharmaceuticals (NASDAQ: VTAE) have entered into a Controlled Equity OfferingSM Sales Agreement (the Sales Agreement) with Cantor ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE